{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:03:53Z","timestamp":1753891433267,"version":"3.41.2"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>In recent years, cancer research has made huge advances also thanks to the discovery of the role of non-coding RNAs in the control of tumorigenesis, tumor proliferation, migration and metastasis and therefore also in the diagnosis and therapy of tumors. This work aims to review the most recent literature involving the study of miRNAs in ocular tumors affecting adult patients. We will introduce the role of miRNAs in tumorigenesis, and we will focus on summarizing the studies on uveal intraocular melanomas in which a role of microRNAs has been demonstrated. Similarly, we will also cover observations on miRNAs and eyelid cancers, especially sebaceous gland carcinoma, and cancers of the conjunctiva and the retina, excluding retinoblastoma which is typically a pediatric-onset tumor. We will summarize specific miRNAs that could be considered as diagnostic molecules or as therapeutic targets against some ocular cancer diseases, indicating their potentialities and limitations, considering also their administration as nanomedicine for the eye.<\/jats:p>","DOI":"10.3389\/fmolb.2025.1459761","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:13:00Z","timestamp":1746677580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of miRNA in adult ocular tumorigenesis"],"prefix":"10.3389","volume":"12","author":[{"given":"Arianna","family":"Romani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Melloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bompan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Zauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Secchiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Zauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Previati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Voltan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molimm.2013.11.018","article-title":"Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease","volume":"58","author":"Achberger","year":"2014","journal-title":"Mol. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/pharmaceutics13020151","article-title":"The antifungal and ocular permeation of ketoconazole from ophthalmic formulations containing trans-ethosomes nanoparticles","volume":"13","author":"Ahmed","year":"2021","journal-title":"Pharmaceutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/nar\/gkz097","article-title":"An estimate of the total number of true human miRNAs","volume":"47","author":"Alles","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.toxrep.2020.11.001","article-title":"The role of MiRNA-21 in gliomas: hope for a novel therapeutic intervention?","volume":"7","author":"Aloizou","year":"2020","journal-title":"Toxicol. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/gerona\/glu180","article-title":"MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors","volume":"70","author":"Badi","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/OPTH.S199064","article-title":"Blood biomarkers of uveal melanoma: current perspectives","volume":"14","author":"Bande Rodr\u00edguez","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.3390\/cancers13235919","article-title":"Do extracellular RNAs provide insight into uveal melanoma biology?","volume":"13","author":"Barbagallo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41416-022-01723-8","article-title":"Future perspectives of uveal melanoma blood based biomarkers","volume":"126","author":"Beasley","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1586\/eop.11.23","article-title":"Retinal tumors in adults: diagnosis and management","volume":"6","author":"Bechrakis","year":"2011","journal-title":"Expert Rev. Ophthalmol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/bjophthalmol-2016-309460","article-title":"miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma","volume":"101","author":"Bhardwaj","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1038\/s41598-018-25900-z","article-title":"MicroRNA and transcriptome analysis in periocular sebaceous gland carcinoma","volume":"8","author":"Bladen","year":"2018","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00417-011-1885-4","article-title":"MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2","volume":"250","author":"Cai","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/ijms25042124","article-title":"Classical and innovative evidence for therapeutic strategies in retinal dysfunctions","volume":"25","author":"Caruso","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.3390\/cancers15143593","article-title":"State of the art of pharmacological activators of p53 in ocular malignancies","volume":"15","author":"Casciano","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/ijms25031689","article-title":"Retinal alterations predict early prodromal signs of neurodegenerative disease","volume":"25","author":"Casciano","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-019-1078-2","article-title":"MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41556-019-0345-y","article-title":"An ARF6-Exportin-5 axis delivers pre-miRNA cargo to tumour microvesicles","volume":"21","author":"Clancy","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/cells10082069","article-title":"MicroRNAs patterns as potential tools for diagnostic and prognostic follow-up in cancer survivorship","volume":"10","author":"Conti","year":"2021","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/cells9010220","article-title":"miRNAs as influencers of cell-cell communication in tumor microenvironment","volume":"9","author":"Conti","year":"2020","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1158\/1535-7163.MCT-14-0209","article-title":"Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer","volume":"13","author":"Daige","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/cells12192380","article-title":"The present and future of optic pathway glioma therapy","volume":"12","author":"Dal","year":"2023","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1167\/iovs.09-3520","article-title":"Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells","volume":"50","author":"Dalgard","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/ceo.13304","article-title":"Emerging diagnostic tests for vitreoretinal lymphoma: a review","volume":"46","author":"Dawson","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1906426","DOI":"10.1002\/smll.201906426","article-title":"Combined replenishment of miR-34a and let-7b by targeted nanoparticles inhibits tumor growth in neuroblastoma preclinical models","volume":"16","author":"Di Paolo","year":"2020","journal-title":"Small"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/life14010155","article-title":"Nutlin-3 loaded ethosomes and transethosomes to prevent UV-associated skin damage","volume":"14","author":"Esposito","year":"","journal-title":"Life (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.2147\/IJN.S452134","article-title":"Microfluidic fabricated liposomes for nutlin-3a ocular delivery as potential candidate for proliferative vitreoretinal diseases treatment","volume":"19","author":"Esposito","year":"","journal-title":"Int. J. Nanomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3892\/mmr.2019.9949","article-title":"Prognostic significance of deregulated microRNAs in uveal melanomas","volume":"19","author":"Falzone","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cjp2.86","article-title":"Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma","volume":"4","author":"Farquhar","year":"2017","journal-title":"J. Pathol. Clin. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"774624","DOI":"10.3389\/fmed.2021.774624","article-title":"The Xiangya ocular Tumor Bank: a disease-specific biobank for advancing translational research into ocular tumors","volume":"8","author":"Gao","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2261278","DOI":"10.1080\/2162402X.2023.2261278","article-title":"Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients","volume":"12","author":"Garc\u00eda-Mulero","year":"2023","journal-title":"Oncoimmunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"CD005643","DOI":"10.1002\/14651858.CD005643.pub2","article-title":"Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals","author":"Gichuhi","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"B37","first-page":"2476","article-title":"MiR-26a inhibits proliferation and apoptosis of uveal melanoma cells via regulating p53\/MDM2 pathway","volume":"25","author":"Guo","year":"2020","journal-title":"J. BUON"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/mmr.2020.11682","article-title":"Bioinformatics analysis of the microRNA-mRNA network in sebaceous gland carcinoma of the eyelid","volume":"23","author":"Hirano","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1167\/iovs.13-12272","article-title":"MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease","volume":"54","author":"Hother","year":"2013","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ajo.2005.05.034","article-title":"Population-based incidence of uveal melanoma in various races and ethnic groups","volume":"140","author":"Hu","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-vision-100419-115156","article-title":"Retina metabolism and metabolism in the pigmented epithelium: a busy intersection","volume":"7","author":"Hurley","year":"2021","journal-title":"Annu. Rev. Vis. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.3390\/ijms23116226","article-title":"Potential of aqueous humor as a liquid biopsy for uveal melanoma","volume":"23","author":"Im","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bjo-2023-324132","article-title":"New insights on the role of microRNAs in retinal M\u00fcller glial cell function","volume":"108","author":"Jiang","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1182\/blood-2017-01-765180","article-title":"Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma","volume":"129","author":"Kakkassery","year":"2017","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.sjopt.2018.12.008","article-title":"Primary vitreoretinal lymphoma","volume":"33","author":"Kalogeropoulos","year":"2019","journal-title":"Saudi J. Ophthalmol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/jnci\/djp376","article-title":"Targeted molecular therapy for neuroblastoma: the ARF\/MDM2\/p53 axis","volume":"101","author":"Kim","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14744\/bej.2020.28290","article-title":"Importance of m\u00fcller cells","volume":"5","author":"Kobat","year":"2020","journal-title":"Beyoglu Eye J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1167\/iovs.16-19862","article-title":"MicroRNA expression profile in conjunctival melanoma","volume":"57","author":"Larsen","year":"2016","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18240\/ijo.2022.01.01","article-title":"Effect of miR-184 and miR-205 on the tumorigenesis of conjunctival mucosa associated lymphoid tissue lymphoma through regulating RasL10B and TNFAIP8","volume":"15","author":"Li","year":"2022","journal-title":"Int. J. Ophthalmol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.actbio.2022.11.016","article-title":"A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma","volume":"155","author":"Ma","year":"2023","journal-title":"Acta Biomater."},{"key":"B57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.fsc.2010.05.002","article-title":"Complications in periocular rejuvenation","volume":"18","author":"Mack","year":"2010","journal-title":"Facial Plast. Surg. Clin. North Am."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/cells12202506","article-title":"Mutant p53 gain-of-function induces migration and invasion through overexpression of miR-182-5p in cancer cells","volume":"12","author":"Madrigal","year":"2023","journal-title":"Cells"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3390\/cancers15082372","article-title":"Need for a dedicated ophthalmic malignancy clinico-biological biobank: the Nice ocular MAlignancy (NOMA) biobank","volume":"15","author":"Martel","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the U.S","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"6908","DOI":"10.3390\/curroncol29100543","article-title":"Primary vitreoretinal lymphoma: current diagnostic laboratory tests and new emerging molecular tools","volume":"29","author":"Melli","year":"2022","journal-title":"Curr. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/CMR.0000000000000606","article-title":"Global microRNA profiling of metastatic conjunctival melanoma","volume":"29","author":"Mikkelsen","year":"2019","journal-title":"Melanoma Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3390\/jcm9061844","article-title":"High-throughput MicroRNA profiling of vitreoretinal lymphoma: vitreous and serum MicroRNA profiles distinct from uveitis","volume":"9","author":"Minezaki","year":"2020","journal-title":"J. Clin. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"863734","DOI":"10.1155\/2011\/863734","article-title":"Recent applications of liposomes in ophthalmic drug delivery","volume":"2011","author":"Mishra","year":"2011","journal-title":"J. Drug Deliv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00403-024-03163-1","article-title":"Upper and lower eyelid malignancies: differences in clinical presentation, metastasis, and treatment","volume":"316","author":"Mukarram","year":"2024","journal-title":"Arch. Dermatol Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jtos.2019.04.002","article-title":"MicroRNAs in the cornea: role and implications for treatment of corneal neovascularization","volume":"17","author":"Mukwaya","year":"2019","journal-title":"Ocul. Surf."},{"key":"B67","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4103\/IJO.IJO_2414_23","article-title":"Retinoblastoma - a comprehensive review, update and recent advances","volume":"72","author":"Nag","year":"2024","journal-title":"Indian J. Ophthalmol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e0132767","DOI":"10.1371\/journal.pone.0132767","article-title":"miR-34 and p53: new insights into a complex functional relationship","volume":"10","author":"Navarro","year":"2015","journal-title":"PLoS One"},{"key":"B69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.omto.2022.04.001","article-title":"CRISPR-Cas knockout of miR21 reduces glioma growth","volume":"25","author":"Nieland","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e15155","DOI":"10.1016\/j.heliyon.2023.e15155","article-title":"p53\/MicroRNA-34 axis in cancer and beyond","volume":"9","author":"Pan","year":"2023","journal-title":"Heliyon"},{"key":"B72","doi-asserted-by":"publisher","first-page":"12807","DOI":"10.3390\/ijms241612807","article-title":"Genetic and epigenetic features of uveal melanoma-an Overview and clinical implications","volume":"24","author":"Pa\u0161ali\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.jcjo.2023.10.024","article-title":"Multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing","volume":"27","author":"Pike","year":"2023","journal-title":"Can. J. Ophthalmol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1080\/15384047.2015.1046021","article-title":"miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: pathological and diagnostic implications","volume":"16","author":"Ragusa","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"B75","first-page":"430","article-title":"MicroRNAs in vitreus humor from patients with ocular diseases","volume":"19","author":"Ragusa","year":"2013","journal-title":"Mol. Vis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2010.08.028","article-title":"Barrier analysis of periocular drug delivery to the posterior segment","volume":"148","author":"Ranta","year":"2010","journal-title":"J. Control Release"},{"key":"B77","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000509918","article-title":"Five decades of enucleations for uveal melanoma in one center: more tumors with high risk factors, No improvement in survival over time","volume":"7","author":"Roelofsen","year":"2021","journal-title":"Ocul. Oncol. Pathol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1000677","DOI":"10.3389\/fonc.2022.1000677","article-title":"MDM2 inhibitors-mediated disruption of mitochondrial metabolism: a novel therapeutic strategy for retinoblastoma","volume":"12","author":"Romani","year":"2022","journal-title":"Front. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.3390\/ijms20215447","article-title":"Conjunctival melanoma: genetic and epigenetic insights of a distinct type of melanoma","volume":"20","author":"Rossi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fphar.2016.00424","article-title":"Increased levels of miRNA-146a in serum and histologic samples of patients with uveal melanoma","volume":"7","author":"Russo","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/cancers12092538","article-title":"Orbital and eyelid B-cell lymphoma: a multicenter retrospective study","volume":"12","author":"Savino","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ophtha.2005.04.020","article-title":"Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis","volume":"112","author":"Shah","year":"2005","journal-title":"Ophthalmology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2217\/epi-2019-0029","article-title":"Altered expression profile of circular RNAs in conjunctival melanoma","volume":"11","author":"Shang","year":"2019","journal-title":"Epigenomics"},{"key":"B84","doi-asserted-by":"publisher","first-page":"eaba1606","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci. Adv."},{"key":"B85","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.4103\/ijo.IJO_2040_19","article-title":"Tumors of the conjunctiva and cornea","volume":"67","author":"Shields","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.3390\/cancers14133066","article-title":"GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma","volume":"14","author":"Silva-Rodr\u00edguez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.22608\/APO.201701","article-title":"What's new in eyelid tumors","volume":"6","author":"Silverman","year":"2017","journal-title":"Asia Pac J. Ophthalmol. (Phila)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/cancers11060815","article-title":"Aberrant MicroRNA expression and its implications for uveal melanoma metastasis","volume":"11","author":"Smit","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B91","first-page":"1569","article-title":"Age-dependent increase in miRNA-34a expression in the posterior pole of the mouse eye","volume":"20","author":"Smit-McBride","year":"2014","journal-title":"Mol. Vis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.3390\/cancers13163921","article-title":"Vitreoretinal lymphoma","volume":"13","author":"Sobolewska","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/cancers13164020","article-title":"MiRNAs correlate with HLA expression in uveal melanoma: both up- and downregulation are related to monosomy 3","volume":"13","author":"Souri","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.8.6.12","article-title":"A panel of circulating MicroRNAs detects uveal melanoma with high precision","volume":"8","author":"Stark","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jamaophthalmol.2015.2310","article-title":"Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs","volume":"133","author":"Tetzlaff","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"684712","DOI":"10.3389\/fphar.2021.684712","article-title":"Mini review: current trends and understanding of exosome therapeutic potential in corneal diseases","volume":"12","author":"Tiwari","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13148-016-0243-0","article-title":"Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma","volume":"8","author":"Triozzi","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"B98","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ajo.2013.12.014","article-title":"Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis","volume":"157","author":"Tuo","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"123021","DOI":"10.1016\/j.ijpharm.2023.123021","article-title":"Timolol-loaded ethosomes for ophthalmic delivery: reduction of high intraocular pressure in vivo","volume":"640","author":"Uner","year":"2023","journal-title":"Int. J. Pharm."},{"key":"B100","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/IJN.S12125","article-title":"Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method","volume":"5","author":"Urb\u00e1n-Morl\u00e1n","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"B101","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/bjc.2017.259","article-title":"GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi","volume":"117","author":"Vader","year":"2017","journal-title":"Br. J. Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e0146128","DOI":"10.1371\/journal.pone.0146128","article-title":"Clinico-pathological association of delineated miRNAs in uveal melanoma with monosomy 3\/disomy 3 chromosomal aberrations","volume":"11","author":"Venkatesan","year":"2016","journal-title":"PLoS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/cancers14051221","article-title":"Epigenetic regulation: a link between inflammation and carcinogenesis","volume":"14","author":"Vezzani","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"Incidence of uveal melanoma in Europe","volume":"114","author":"Virgili","year":"2007","journal-title":"Ophthalmology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B107","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1101\/gr.098046.109","article-title":"Reprogramming of miRNA networks in cancer and leukemia","volume":"20","author":"Volinia","year":"2010","journal-title":"Genome Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pharmaceutics13020288","article-title":"Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases","volume":"13","author":"Wan","year":"2021","journal-title":"Pharmaceutics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.18240\/ijo.2018.08.03","article-title":"Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein","volume":"11","author":"Wang","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/CMR.0b013e3282feeac6","article-title":"Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling","volume":"18","author":"Worley","year":"2008","journal-title":"Melanoma Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/genes11030271","article-title":"The potential role of selected miRNA in uveal melanoma primary tumors as early biomarkers of disease progression","volume":"11","author":"Wr\u00f3blewska","year":"2020","journal-title":"Genes (Basel)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1167\/iovs.19-27704","article-title":"Long noncoding RNA PVT1 silencing prevents the development of uveal melanoma by impairing MicroRNA-17-3p-dependent MDM2 upregulation","volume":"60","author":"Wu","year":"2019","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e40967","DOI":"10.1371\/journal.pone.0040967","article-title":"Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2","volume":"7","author":"Yan","year":"2012","journal-title":"PLoS One"},{"key":"B114","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.3390\/cancers13205192","article-title":"Potential of miRNA-based nanotherapeutics for uveal melanoma","volume":"13","author":"Yang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1158\/1078-0432.CCR-10-3244","article-title":"miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells","volume":"17","author":"Zauli","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/ol.2021.13094","article-title":"MicroRNA-3907 promotes the proliferation and migration of sebaceous gland carcinoma of the eyelid by targeting thrombospondin 1","volume":"22","author":"Zhang","year":"2021","journal-title":"Oncol. Lett."},{"key":"B117","doi-asserted-by":"publisher","first-page":"517","DOI":"10.21037\/atm-21-3897","article-title":"Overexpression of miR-651-5p inhibits ultraviolet radiation-induced malignant biological behaviors of sebaceous gland carcinoma cells by targeting ZEB2","volume":"10","author":"Zhao","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"854253","DOI":"10.3389\/fonc.2022.854253","article-title":"Circulating MicroRNAs as quantitative biomarkers for diagnosis and prognosis of uveal melanoma","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/genes10050377","article-title":"Retinal miRNA functions in health and disease","volume":"10","author":"Zuzic","year":"2019","journal-title":"Genes (Basel)"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2025.1459761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:13:01Z","timestamp":1746677581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2025.1459761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":118,"alternative-id":["10.3389\/fmolb.2025.1459761"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2025.1459761","relation":{},"ISSN":["2296-889X"],"issn-type":[{"type":"electronic","value":"2296-889X"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"article-number":"1459761"}}